Because ALDH1A3 is expressed higher in prostate cancer than in other cancers, it suggests that it may have some specificity as a diagnostic or prognostic marker for prostate cancer, this specificity helps identify prostate cancer patients, and may be useful for monitoring disease progression or risk of recurrence. This evidence concerns the gene ALDH1A3 and prostate cancer.